Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 9842619, 8 pages
http://dx.doi.org/10.1155/2016/9842619
Research Article

Periostin Facilitates the Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells through ILK-Akt Signaling Pathway

Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Jinan, Shandong 250012, China

Received 22 November 2015; Revised 2 February 2016; Accepted 15 February 2016

Academic Editor: Koichiro Wada

Copyright © 2016 Qiao-mei Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Hughes, W. G. Foster, and S. K. Agarwal, “The impact of endometriosis across the lifespan of women: foreseeable research and therapeutic prospects,” BioMed Research International, vol. 2015, Article ID 158490, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Viganò, F. Parazzini, E. Somigliana, and P. Vercellini, “Endometriosis: epidemiology and aetiological factors,” Best Practice & Research: Clinical Obstetrics & Gynaecology, vol. 18, no. 2, pp. 177–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. E. B. Janssen, A. C. M. Rijkers, K. Hoppenbrouwers, C. Meuleman, and T. M. D'Hooghe, “Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review,” Human Reproduction Update, vol. 19, no. 5, pp. 570–582, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Sampson, “Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity,” American Journal of Obstetrics and Gynecology, vol. 14, no. 4, pp. 422–469, 1927. View at Publisher · View at Google Scholar
  5. S. M. Frisch and H. Francis, “Disruption of epithelial cell-matrix interactions induces apoptosis,” Journal of Cell Biology, vol. 124, no. 4, pp. 619–626, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Paoli, E. Giannoni, and P. Chiarugi, “Anoikis molecular pathways and its role in cancer progression,” Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, vol. 1833, no. 12, pp. 3481–3498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Huber, N. Kraut, and H. Beug, “Molecular requirements for epithelial–mesenchymal transition during tumor progression,” Current Opinion in Cell Biology, vol. 17, no. 5, pp. 548–558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Puisieux, T. Brabletz, and J. Caramel, “Oncogenic roles of EMT-inducing transcription factors,” Nature Cell Biology, vol. 16, no. 6, pp. 488–494, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Tania, M. A. Khan, and J. Fu, “Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer,” Tumor Biology, vol. 35, no. 8, pp. 7335–7342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. T. E. Anwar and C. G. Kleer, “Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer,” Human Pathology, vol. 44, no. 8, pp. 1457–1464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Mirantes, I. Espinosa, I. Ferrer, X. Dolcet, J. Prat, and X. Matias-Guiu, “Epithelial-to-mesenchymal transition and stem cells in endometrial cancer,” Human Pathology, vol. 44, no. 10, pp. 1973–1981, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Vergara, B. Merlot, J.-P. Lucot et al., “Epithelial–mesenchymal transition in ovarian cancer,” Cancer Letters, vol. 291, no. 1, pp. 59–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Bartley, A. Jülicher, B. Hotz, S. Mechsner, and H. Hotz, “Epithelial to mesenchymal transition (EMT) seems to be regulated differently in endometriosis and the endometrium,” Archives of Gynecology and Obstetrics, vol. 289, no. 4, pp. 871–881, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Matsuzaki and C. Darcha, “Epithelial to mesenchymal transition-like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesis of pelvic endometriosis,” Human Reproduction, vol. 27, no. 3, pp. 712–721, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. R. S. Ismail, R. L. Baldwin, J. Fang et al., “Differential gene expression between normal and tumor-derived ovarian epithelial cells,” Cancer Research, vol. 60, no. 23, pp. 6744–6749, 2000. View at Google Scholar · View at Scopus
  16. X. Wang, J. Liu, Z. Wang et al., “Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells,” PLoS ONE, vol. 8, no. 8, Article ID e72962, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Lv, W. Wang, W.-D. Jia et al., “High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma,” Medical Oncology, vol. 30, no. 1, article 385, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. C. J. Kim, K. Sakamoto, Y. Tambe, and H. Inoue, “Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells,” International Journal of Oncology, vol. 38, no. 6, pp. 1759–1766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Yan and R. Shao, “Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation,” The Journal of Biological Chemistry, vol. 281, no. 28, pp. 19700–19708, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Ouyang, M. Liu, K. Ruan, G. Song, Y. Mao, and S. Bao, “Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB pathway,” Cancer Letters, vol. 281, no. 2, pp. 213–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Utispan, J. Sonongbua, P. Thuwajit et al., “Periostin activates integrin α5β1 through a PI3K/AKT-dependent, pathway in invasion of cholangiocarcinoma,” International Journal of Oncology, vol. 41, no. 3, pp. 1110–1118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Jiang, J. Wang, K. Zhang, S. Tang, C. Ren, and Y. Chen, “The role of CD29-ILK-Akt signaling-mediated epithelial–mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells,” Medical Oncology, vol. 32, no. 5, article 141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Shen, P. Liu, P. Zhang, X. Zhang, and J. Cui, “Characterization of periostin expression in human endometrium and endometriotic lesions,” Gynecological Endocrinology, vol. 28, no. 10, pp. 815–818, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Xu, Q. Zheng, Z. Zhang, X. Zhang, R. Liu, and P. Liu, “Periostin enhances migration, invasion, and adhesion of human endometrial stromal cells through integrin-linked kinase 1/Akt signaling pathway,” Reproductive Sciences, vol. 22, no. 9, pp. 1098–1106, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Liu, J. Zheng, C. Li et al., “Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression,” Archives of Gynecology and Obstetrics, vol. 291, no. 6, pp. 1361–1369, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Ratajczak-Wielgomas and P. Dziegiel, “The role of periostin in neoplastic processes,” Folia Histochemica et Cytobiologica, vol. 53, no. 2, pp. 120–132, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Morra and H. Moch, “Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update,” Virchows Archiv, vol. 459, no. 5, pp. 465–475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Hu, S. Tong, X. Zhao et al., “Periostin mediates TGF-β-induced epithelial mesenchymal transition in prostate cancer cells,” Cellular Physiology and Biochemistry, vol. 36, no. 2, pp. 799–809, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Chen, S. Zheng, Y. Liu, J. Shi, and S. Qi, “Periostin activates pathways involved in epithelial–mesenchymal transition in adamantinomatous craniopharyngioma,” Journal of the Neurological Sciences, vol. 360, pp. 49–54, 2016. View at Publisher · View at Google Scholar
  30. S.-Q. Wu, Y.-E. Lv, B.-H. Lin et al., “Silencing of periostin inhibits nicotine-mediated tumor cell growth and epithelial-mesenchymal transition in lung cancer cells,” Molecular Medicine Reports, vol. 7, no. 3, pp. 875–880, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Gaetje, S. Kotzian, G. Herrmann, R. Baumann, and A. Starzinski-Powitz, “Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin,” The American Journal of Pathology, vol. 150, no. 2, pp. 461–467, 1997. View at Google Scholar · View at Scopus
  32. K. M. Eyster, A. L. Boles, J. D. Brannian, and K. A. Hansen, “DNA microarray analysis of gene expression markers of endometriosis,” Fertility and Sterility, vol. 77, no. 1, pp. 38–42, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Zhang, Y. Niu, J. Feng, H. Guo, X. Ye, and H. Cui, “Use of proteomic analysis of endometriosis to identify different protein expression in patients with endometriosis versus normal controls,” Fertility and Sterility, vol. 86, no. 2, pp. 274–282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Kim, H. Y. Kang, E.-H. Nam et al., “TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin α5 and its signaling pathways,” Carcinogenesis, vol. 31, no. 4, pp. 597–606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. P. Shah, M. Y. Fong, and S. S. Kakar, “PTTG induces EMT through integrin αVβ3-focal adhesion kinase signaling in lung cancer cells,” Oncogene, vol. 31, no. 26, pp. 3124–3135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Hannigan, A. A. Troussard, and S. Dedhar, “Integrin-linked kinase: a cancer therapeutic target unique among its ILK,” Nature Reviews Cancer, vol. 5, no. 1, pp. 51–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Chen, Y. Zhang, X. Zhang et al., “Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes,” Acta Histochemica, vol. 115, no. 2, pp. 128–136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Yan, H. Yin, R. Wang et al., “Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-κB signaling,” Acta Histochemica, vol. 116, no. 3, pp. 527–533, 2014. View at Publisher · View at Google Scholar
  39. L. A. Shirley, S. McCarty, M. Yang et al., “Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target,” Surgery, vol. 159, no. 1, pp. 163–171, 2016. View at Publisher · View at Google Scholar
  40. S. Yan, X. Han, H. Xue et al., “Let-7f inhibits glioma cell proliferation, migration, and invasion by targeting periostin,” Journal of Cellular Biochemistry, vol. 116, no. 8, pp. 1680–1692, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Irie, M. Kashiwabara, A. Yamada, and K. Asano, “Suppressive activity of quercetin on periostin functions in vitro,” In Vivo, vol. 30, no. 1, pp. 17–25, 2016. View at Google Scholar